Alternative Blood Test More Effective for Guiding Heart Disease Treatment
Research indicates that apolipoprotein B testing outperforms standard LDL cholesterol tests in predicting risk and guiding therapy.
Category: Cardiovascular
Cardiovascular
Latest
Cardiovascular
Latest
Lipoprotein Profiling May Be Diagnostic Key for Heart Disease Risk
Researchers have successfully adapted high-field NMR-based lipoprotein analysis to cost-effective benchtop NMR systems.
Cardiovascular
Latest
New Test Shows Promising Results in Predicting Cardiovascular Risk in ACS Patients
Prolocor detailed positive results from a trial confirming its pFCG test predicts the risk of thrombotic events in ACS patients.
ADLM Publishes Guidance on Lipid Testing for Cardiovascular Disease
ADLM released guidelines to standardize lipid testing, aiming to improve the effectiveness of cardiovascular disease risk assessment.
Read More
At-Home Saliva Test Quickly Detects Signs of Heart Failure
Researchers developed a POC electrochemical biosensor prototype designed to provide at-home screening capabilities for heart failure.
Read More
ApoB Test May More Accurately Measure Heart Disease Risk
A study reveals that lipid panels may not fully capture the risk of cholesterol-related heart disease, highlighting a need for apoB testing.
Read More
Prevencio Granted Patent for AI-Driven Blood Test for Heart Disease
Prevencio received a patent for its AI-powered blood test which accurately assesses the risk of obstructive coronary artery disease.
Read More
AI-Based Cardiac Analysis of Flies Could Support Human Cardiovascular Disease Diagnosis
Researchers developed a machine learning method that utilizes deep learning and video microscopy to automate the analysis of heart dynamics.
Read More
Siemens Healthineers Adds New Heart Failure Assay to Cardiac Test Menu
Siemens Healthineers introduced the NT-proBNPII assay to its Atellica Solution, enhancing rapid diagnostic capabilities for heart failure.
Read More
Roche’s Lipoprotein Blood Test Gets Breakthrough Device Designation
Roche announced that its Tina-quant lipoprotein Lp(a) RxDx assay received Breakthrough Device Designation from the FDA.
Read More
A Genetic Test for Early Cardiovascular Risk Detection
Researchers developed a genetic testing procedure that can identify patients at high risk for cardiovascular diseases.
Read More
Advanced Cardiovascular POC Testing System Gets FDA Clearance
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Read More
FDA Clears Cardiac Troponin I Test for Myocardial Infarction Diagnosis
The new high-sensitivity troponin assay is designed for use on the the PATHFAST Biomarker Analyzer from Polymedco.
Read More
Heart Failure Monitoring Tech Doubles Sensitivity for Predicting Events Versus Standard of Care
Bodyport says its biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events.
Read More
Blood Biomarkers Help Predict Cardiovascular Disease Risk in Rheumatoid Arthritis Patients
The measurement of six blood biomarkers improved the ability of researchers to predict a future increase in arterial inflammation.Â
Read More
How a Standard Blood Test Helps Predict Heart Attacks
Combining the results of a standard blood test and an online tool can help identify those who are at risk of having a heart attack.
Read More
Biomarkers to Predict Cardiovascular Risks in Type 2 Diabetes Patients Identified
Researchers extracted data on 321 biomarkers and found 13 were significantly associated with cardiovascular risk in type 2 diabetes patients.
Read More
Two Common Biomarkers Predict Heart Risk in Asymptomatic Childhood Cancer Survivors
The biomarkers may help more quickly predict cardiomyopathy in high-risk, asymptomatic childhood cancer survivors.Â
Read More